TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 4,205.00
+520.00 (14.11%)
At close: Jun 29, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 126.31 billion as of June 29, 2026. Its market cap has decreased by -26.05% in one year.
Market Cap
126.31B
Enterprise Value
130.42B
Revenue
13.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,205.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 126.31B, a decrease of -59.50%. That is a compound annual growth rate of -12.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 126.31B | -25.95% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 165.59B |
| Genome & Company | 161.29B |
| Bio Solution | 152.25B |
| Prestige Biologics | 151.23B |
| ISU Abxis | 129.26B |
| ViGenCell | 123.61B |
| NovMetaPharma | 107.87B |
| Cell Biotech | 102.66B |